National Health Investors (NHI)
(Delayed Data from NYSE)
$62.61 USD
-0.24 (-0.38%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $62.61 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth D Momentum F VGM
Income Statements
Fiscal Year end for National Health Investors, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 320 | 278 | 299 | 333 | 318 |
Cost Of Goods | 40 | 28 | 0 | 0 | 0 |
Gross Profit | 280 | 250 | 299 | 333 | 318 |
Selling & Adminstrative & Depr. & Amort Expenses | 103 | 169 | 165 | 109 | 101 |
Income After Depreciation & Amortization | 177 | 81 | 133 | 224 | 218 |
Non-Operating Income | 15 | 29 | 29 | 14 | -1 |
Interest Expense | 58 | 45 | 51 | 53 | 56 |
Pretax Income | 134 | 66 | 112 | 185 | 160 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | -1 | -1 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 134 | 66 | 112 | 185 | 160 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 136 | 66 | 112 | 185 | 160 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 254 | 163 | 219 | 313 | 300 |
Depreciation & Amortization (Cash Flow) | 77 | 82 | 85 | 89 | 82 |
Income After Depreciation & Amortization | 177 | 81 | 133 | 224 | 218 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 43.39 | 44.79 | 45.73 | 44.70 | 43.70 |
Diluted EPS Before Non-Recurring Items | 3.13 | 1.48 | 2.44 | 4.14 | 3.67 |
Diluted Net EPS (GAAP) | 3.13 | 1.48 | 2.44 | 4.14 | 3.67 |
Fiscal Year end for National Health Investors, Inc falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 79.47 | 80.11 | 77.88 | 82.39 |
Cost Of Goods | NA | 10.06 | 10.05 | 9.68 | 9.80 |
Gross Profit | NA | 69.40 | 70.06 | 68.19 | 72.59 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 24.61 | 26.89 | 25.87 | 25.78 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 44.79 | 43.17 | 42.32 | 46.81 |
Non-Operating Income | NA | 1.02 | 0.94 | 11.31 | 1.40 |
Interest Expense | NA | 14.85 | 15.09 | 14.19 | 14.03 |
Pretax Income | NA | 31.72 | 29.03 | 39.45 | 34.18 |
Income Taxes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | NA | -0.33 | -0.31 | -0.33 | -0.30 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | 31.72 | 29.03 | 39.45 | 34.18 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | 32.04 | 29.35 | 39.78 | 34.48 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 43.39 | 43.39 | 43.39 | 43.39 |
Diluted EPS Before Non-Recurring Items | NA | 0.74 | 0.68 | 0.92 | 0.79 |
Diluted Net EPS (GAAP) | NA | 0.74 | 0.68 | 0.92 | 0.79 |